Magic mushrooms do not contain N,N-DMT, the compound found in ayahuasca and certain plant extracts. They contain psilocybin and psilocin, which are chemically related to DMT but are distinct molecules with different properties. The confusion is understandable because psilocin’s full chemical name is literally 4-hydroxy-N,N-dimethyltryptamine (4-HO-DMT), which has “DMT” right in the name. But that naming convention reflects a shared molecular backbone, not an identical substance.
Why People Confuse Psilocybin With DMT
Psilocybin, psilocin, and N,N-DMT all belong to the same chemical family: tryptamines. They share a core structure built from the amino acid tryptophan, the same building block your body uses to make serotonin and melatonin. The difference comes down to small but important modifications on that shared skeleton.
N,N-DMT is the simplest version: a tryptamine backbone with two methyl groups attached to the nitrogen. Psilocin is that same molecule plus a hydroxyl group (an oxygen-hydrogen pair) added at a specific position on the ring structure. Psilocybin is psilocin with an additional phosphate group tacked onto that hydroxyl. These modifications change how each molecule behaves in your body, how long it lasts, and how potently it binds to receptors in the brain.
Think of it like three variations of the same car chassis. They look similar on paper, but the engines, transmissions, and handling are all different.
What Magic Mushrooms Actually Contain
The primary psychoactive compounds in Psilocybe mushrooms are psilocybin and psilocin. Quantitative analysis of Psilocybe cubensis, the most commonly cultivated species, shows psilocybin content around 3.26% of dried weight, with psilocin at roughly 0.34%. The mushrooms also contain smaller amounts of related compounds like baeocystin and norbaeocystin, but N,N-DMT is not part of their chemical profile.
The biosynthetic pathway these mushrooms use to produce psilocybin doesn’t involve DMT as an intermediate step. Four enzymes work in sequence, starting with tryptophan. The pathway first adds a hydroxyl group to the tryptamine structure, then attaches a phosphate group, and finally adds methyl groups one at a time. The result is psilocybin. At no point does the mushroom produce free N,N-DMT along the way.
How They Work Differently in the Brain
When you eat a psilocybin mushroom, enzymes in your liver and gut strip off that phosphate group, converting psilocybin into psilocin. Psilocin is the molecule that actually crosses into the brain and produces psychedelic effects. Both psilocin and DMT activate the same primary target, the serotonin 2A receptor, but psilocin binds to it roughly ten times more tightly. Psilocin’s binding affinity is in the tens of nanomolar range, while DMT’s is in the hundreds. Psilocin also interacts broadly with other serotonin receptor subtypes, which contributes to its particular character of effects.
DMT, by contrast, also hits dopamine receptors more prominently, which may account for some of the differences people report between the two experiences.
The Experience Is Very Different
Even if psilocin and DMT are molecular cousins, the experiences they produce diverge sharply in timing and character. Psilocybin mushrooms take 30 to 60 minutes to kick in, and the effects last 4 to 6 hours. Inhaled DMT hits almost instantly and lasts only 15 to 30 minutes. That difference alone fundamentally changes the nature of the experience: a mushroom trip unfolds gradually with time to adjust, while a DMT experience is often described as an abrupt, overwhelming immersion.
The structural difference responsible for this is that extra hydroxyl group on psilocin. It makes the molecule more compatible with oral absorption and slower metabolism, giving it a much longer duration of action. DMT, lacking that modification, is rapidly broken down by enzymes in the gut and liver. That’s why DMT is typically inhaled or, in the case of ayahuasca, combined with a plant that inhibits the enzyme responsible for breaking it down.
Where DMT Actually Comes From
N,N-DMT is found in a wide range of plants, not fungi. The most well-known sources are Mimosa hostilis root bark, used in traditional Brazilian “jurema wine” ceremonies, and Psychotria viridis leaves, one of the two key ingredients in ayahuasca. DMT was first identified in Mimosa hostilis roots in 1946 and later recognized as the primary psychoactive component of ayahuasca in 1957.
DMT also occurs naturally in trace amounts in the human body, though its biological role remains poorly understood. It’s produced from tryptophan through a simpler pathway than the one mushrooms use to make psilocybin.
Legal Classification
Both psilocybin and DMT are classified as Schedule I controlled substances under the U.S. Controlled Substances Act of 1970, meaning federal law treats them as having no accepted medical use and high potential for abuse. Several states and cities have moved to decriminalize or deprioritize enforcement around psilocybin specifically, but these local measures exist in tension with federal law. DMT remains tightly restricted everywhere in the U.S., with narrow exceptions for certain religious ceremonies involving ayahuasca.
The fact that both substances share the same legal classification adds to the public confusion between them, but from a chemistry and pharmacology standpoint, they are different compounds found in entirely different organisms.